Cordis Appeals $22M Verdict In Stent Patent Suit
Johnson & Johnson subsidiary Cordis Corp. has appealed a $22 million verdict for Spectralytics Inc. in a patent infringement dispute between the medical device makers over a stent-cutting machine, on the...To view the full article, register now.
Already a subscriber? Click here to view full article